GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Biome Australia Ltd (ASX:BIO) » Definitions » Cash Flow from Financing

Biome Australia (ASX:BIO) Cash Flow from Financing : A$1.39 Mil (TTM As of Dec. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Biome Australia Cash Flow from Financing?

Cash from financing is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders.

For the six months ended in Dec. 2024, Biome Australia received A$1.10 Mil more from issuing new shares than it paid to buy back shares. It spent A$0.02 Mil paying down its debt. It paid A$0.00 Mil more to buy back preferred shares than it received from issuing preferred shares. It received A$0.00 Mil from paying cash dividends to shareholders. It spent A$0.05 Mil on other financial activities. In all, Biome Australia earned A$1.02 Mil on financial activities for the six months ended in Dec. 2024.


Biome Australia Cash Flow from Financing Historical Data

The historical data trend for Biome Australia's Cash Flow from Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biome Australia Cash Flow from Financing Chart

Biome Australia Annual Data
Trend Jun22 Jun23 Jun24
Cash Flow from Financing
8.40 0.67 0.79

Biome Australia Semi-Annual Data
Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Cash Flow from Financing Get a 7-Day Free Trial -0.05 0.71 0.43 0.36 1.02

Biome Australia Cash Flow from Financing Calculation

This is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders. In the calculation of free cash flow, cash from financing is not calculated because it is not related to operating activities.

Biome Australia's Cash from Financing for the fiscal year that ended in Jun. 2024 is calculated as:

Biome Australia's Cash from Financing for the quarter that ended in Dec. 2024 is:


Cash Flow from Financing for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$1.39 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Biome Australia  (ASX:BIO) Cash Flow from Financing Explanation

Cash from financing contains six items:

1. Issuance of Stock:
A company may raise cash from issuing new shares. Issuance of stock represents the cash inflow from offering common stock, which is the additional capital contribution to the entity during the period.

Biome Australia's issuance of stock for the six months ended in Dec. 2024 was A$1.10 Mil.

2. Repurchase of Stock:
A company may raise cash from issuing new shares. It can also use cash to buy back shares. Repurchase of stock represents the cash outflow to reacquire common stock during the period.

Biome Australia's repurchase of stock for the six months ended in Dec. 2024 was A$0.00 Mil.

3. Net Issuance of Debt:
Net issuance of debt is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive.

Biome Australia's net issuance of debt for the six months ended in Dec. 2024 was A$-0.02 Mil. Biome Australia spent A$0.02 Mil paying down its debt.

4. Net Issuance of Preferred Stock:
A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.

Biome Australia's net issuance of preferred for the six months ended in Dec. 2024 was A$0.00 Mil. Biome Australia paid A$0.00 Mil more to buy back preferred shares than it received from issuing preferred shares.

5. Cash Flow for Dividends:
Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Biome Australia's cash flow for dividends for the six months ended in Dec. 2024 was A$0.00 Mil. Biome Australia received A$0.00 Mil from paying cash dividends to shareholders.

6. Other Financing:
Money spent or earned by company from other financial activities.

Biome Australia's other financing for the six months ended in Dec. 2024 was A$-0.05 Mil. Biome Australia spent A$0.05 Mil on other financial activities.


Biome Australia Cash Flow from Financing Related Terms

Thank you for viewing the detailed overview of Biome Australia's Cash Flow from Financing provided by GuruFocus.com. Please click on the following links to see related term pages.


Biome Australia Business Description

Traded in Other Exchanges
N/A
Address
192-194 Johnston Street, Collingwood, VIC, AUS, 3066
Biome Australia Ltd licences, develops, and markets evidence-based, complementary medicines, including nutraceuticals food-based vitamins and weight management products and live biotherapeutics. The firm owns brands namely; Activated Nutrients: a range of completely organic, plant-based, all-in-one nutritional products; Activated Probiotics: a first-of-its-kind range of clinically-backed precision probiotics. The company has one operating segment: researching, developing, manufacturing and distributing innovative evidence-based products linking the gut and human health. Domestically it caters to Australia and In international markets, the Group distributes and markets its Activated Probiotics range in the United Kingdom and New Zealand through independent health practitioners.